A COMPARISON OF STOCKHOLM3, SERUM BIOMARKERS, AND RISK CALCULATORS TO PREDICT PROSTATE CANCER IN A DIVERSE COHORT: EVALUATION OF THE STOCKHOLM3 MULTI-ETHNIC SEPTA TRIAL

Category Primary study
Conference25th annual meeting of the SUO
Year 2025
This article has no abstract
Epistemonikos ID: a9ef16d039c1f07cb0030ec0a9b58488743f3e97
First added on: Mar 14, 2025